Terms: = Gastric cancer AND TET2, Q6N021, MGC125715, KIAA1546, FLJ20032, ENSG00000168769, 54790 AND Clinical Outcome
1 results:
1. Decreased 5-hydroxymethylcytosine (5-hmC) is an independent poor prognostic factor in gastric cancer patients.
Yang Q; Wu K; Ji M; Jin W; He N; Shi B; Hou P
J Biomed Nanotechnol; 2013 Sep; 9(9):1607-16. PubMed ID: 23980508
[TBL] [Abstract] [Full Text] [Related]
